Evidence Level:Resistant: D – Preclinical
Title:
Elevated HMGB1 promotes the malignant progression and contributes to cisplatin resistance of non-small cell lung cancer
Excerpt:HMGB1 overexpression significantly promoted the malignant progression and cisplatin resistance of NSCLC in vitro and in vivo.
DOI:10.1186/s41065-023-00294-9